Stay updated on Pembrolizumab in Esophagogastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Esophagogastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Esophagogastric Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Footer revision updated to v3.4.1, replacing v3.4.0; this is a minor metadata change that does not affect study content or page interactions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T00:31:07.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Added a glossary display option and updated study metadata to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Removed the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-28T21:53:00.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.3 to v3.3.4. This appears to be a minor back-end/formatting change and does not modify the study details or content presented on the page.
    Difference
    0.1%
    Check dated 2026-01-14T04:12:47.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Footer now includes Revision: v3.3.3 and removes HHS Vulnerability Disclosure and Revision: v3.3.2. This update does not affect study details or functionality; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T21:14:58.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Publications description now states that items are automatically filled from PubMed, and the revision tag changed from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T11:12:45.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Removed the general government funding/status notice banner; this site-wide notice did not affect the study details or participation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T06:59:02.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Esophagogastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Esophagogastric Cancer Clinical Trial page.